Article Detail - JF Part B
MolDX Local Coverage Determinations (LCDs) Finalized - Effective August 10, 2026
Date Posted: June 25, 2026
The following Local Coverage Determinations (LCDs) have completed the Open Public Meeting comment period and are now finalized under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).
| Medicare Coverage Database Number | MolDX LCD Title |
|---|---|
| L40197 | MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis |
| Medicare Coverage Database Number | MolDX Billing and Coding Article Title |
|---|---|
| A60217 | Billing and Coding: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis |
| Medicare Coverage Database Number | Response to Comments |
|---|---|
| A60450 | Response to Comments: MolDX: Biomarker Testing in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis |
Effective Date: August 10, 2026
View Active MolDX LCDs on our website or the CMS MCD.